124 related articles for article (PubMed ID: 3766375)
1. Electrophysiologic actions of pirmenol in dogs with recent myocardial infarction.
Lynch JJ; DiCarlo LA; Montgomery DG; Hassan T; Lucchesi BR
Am Heart J; 1986 Oct; 112(4):752-8. PubMed ID: 3766375
[TBL] [Abstract][Full Text] [Related]
2. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects of bepridil in normal and infarcted canine myocardium.
Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR
J Cardiovasc Pharmacol; 1986; 8(5):957-66. PubMed ID: 2429097
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
Liem LB; Clay DA; Franz MR; Swerdlow CD
Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
Patterson E; Gibson JK; Lucchesi BR
Pharmacology; 1988; 36(2):73-83. PubMed ID: 3353442
[TBL] [Abstract][Full Text] [Related]
7. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.
Wallace AA; Stupienski RF; Heaney LA; Gehret JR; Lynch JJ
Am Heart J; 1991 May; 121(5):1413-21. PubMed ID: 1708198
[TBL] [Abstract][Full Text] [Related]
9. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
[TBL] [Abstract][Full Text] [Related]
10. Nonsustained polymorphic ventricular tachycardia induced by electrical stimulation in 3 week old canine myocardial infarction.
Garan H; Fallon JT; Ruskin JN
Am J Cardiol; 1981 Aug; 48(2):280-6. PubMed ID: 7270437
[TBL] [Abstract][Full Text] [Related]
11. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
[TBL] [Abstract][Full Text] [Related]
14. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
Kowey PR; Waxman HL; Greenspon A; Greenberg R; Poll D; Kutalek S; Gessman L; Muenz L
Am J Cardiol; 1990 Mar; 65(9):594-8. PubMed ID: 2309629
[TBL] [Abstract][Full Text] [Related]
15. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E4031 in a canine model of previous myocardial infarction.
Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Selnick HG; Stein RB
J Cardiovasc Pharmacol; 1990 May; 15(5):764-75. PubMed ID: 1692937
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent change in electrophysiologic milieu after myocardial infarction in conscious dogs.
Duff HJ; Martin JM; Rahmberg M
Circulation; 1988 Jan; 77(1):209-20. PubMed ID: 3335068
[TBL] [Abstract][Full Text] [Related]
17. Chronic ventricular tachyarrhythmias in the conscious dog: prevention by UM-272 (dimethylpropranolol).
Patterson E; Lucchesi BR
J Cardiovasc Pharmacol; 1981; 3(4):769-80. PubMed ID: 6167806
[TBL] [Abstract][Full Text] [Related]
18. A model of chronic ischemic arrhythmias: the relation between electrically inducible ventricular tachycardia, ventricular fibrillation threshold and myocardial infarct size.
Gang ES; Bigger JT; Livelli FD
Am J Cardiol; 1982 Sep; 50(3):469-77. PubMed ID: 7113930
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of pirmenol and lidocaine on intraventricular conduction in canine myocardial infarction.
Hashimoto H; Ozaki T; Nagashima S; Nakashima M
J Electrocardiol; 1991 Oct; 24(4):379-85. PubMed ID: 1744550
[TBL] [Abstract][Full Text] [Related]
20. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
